EPSTEIN-BARR-VIRUS LATENCY AND ACTIVATION INVIVO

被引：0
作者：
ERNBERG, I
机构：
来源：
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY | 1990年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：337 / 346
页数：10
相关论文
共 41 条
[1]   EFFECT OF ACYCLOVIR ON INFECTIOUS-MONONUCLEOSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
ANDERSSON, J ;
BRITTON, S ;
ERNBERG, I ;
ANDERSSON, U ;
HENLE, W ;
SKOLDENBERG, B ;
TISELL, A .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (02) :283-290
[2]  
ANDERSSON J, 1985, SCAND J INFECT DIS, P107
[3]   ACYCLOVIR TREATMENT IN INFECTIOUS-MONONUCLEOSIS - A CLINICAL AND VIROLOGICAL STUDY [J].
ANDERSSON, J ;
SKOLDENBERG, B ;
HENLE, W ;
GIESECKE, J ;
ORTQVIST, A ;
JULANDER, I ;
GUSTAVSSON, E ;
AKERLUND, B ;
BRITTON, S ;
ERNBERG, I .
INFECTION, 1987, 15 :S14-S20
[4]  
CHANG RS, 1980, INFECTIOUS MONONUCLE, P130
[5]   PERSISTENCE OF EPSTEIN-BARR VIRAL NUCLEAR ANTIGEN (EBNA) IN CELLS ENTERING EB VIRAL CYCLE [J].
ERNBERG, I ;
MASUCCI, G ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (02) :197-203
[6]  
ERNBERG I, 1988, Cancer Reviews, V10, P92
[7]   THE ROLE OF METHYLATION IN THE PHENOTYPE-DEPENDENT MODULATION OF EPSTEIN-BARR NUCLEAR ANTIGEN-2 AND LATENT MEMBRANE-PROTEIN GENES IN CELLS LATENTLY INFECTED WITH EPSTEIN-BARR VIRUS [J].
ERNBERG, I ;
FALK, K ;
MINAROVITS, J ;
BUSSON, P ;
TURSZ, T ;
MASUCCI, MG ;
KLEIN, G .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :2989-3002
[8]   LYMPHOBLASTOID CELL-LINES AND BURKITTS-LYMPHOMA-DERIVED CELL-LINES DIFFER IN THE EXPRESSION OF A 2ND EPSTEIN-BARR-VIRUS ENCODED NUCLEAR ANTIGEN [J].
ERNBERG, I ;
KALLIN, B ;
DILLNER, J ;
FALK, K ;
EHLINHENRIKSSON, B ;
HAMMARSKJOLD, ML ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (05) :729-737
[9]   ACYCLOVIR EFFICIENTLY INHIBITS OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR-VIRUS IN PATIENTS WITH ACUTE INFECTIOUS-MONONUCLEOSIS [J].
ERNBERG, I ;
ANDERSSON, J .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :2267-2272
[10]  
ERNBERG I, 1989, EPSTEINBARR VIRUS HU, V2, P341
12345